Literature DB >> 18687504

Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease.

Dong-Gyu Jo1, Thiruma V Arumugam, Ha-Na Woo, Jong-Sung Park, Sung-Chun Tang, Mohamed Mughal, Dong-Hoon Hyun, Jun-Hyung Park, Yun-Hyung Choi, A-Ryeong Gwon, Simonetta Camandola, Aiwu Cheng, Huaibin Cai, Weihong Song, William R Markesbery, Mark P Mattson.   

Abstract

Beta-secretase (BACE1), an enzyme responsible for the production of amyloid beta-peptide (Abeta), is increased by oxidative stress and is elevated in the brains of patients with sporadic Alzheimer's disease (AD). Here, we show that oxidative stress fails to induce BACE1 expression in presenilin-1 (gamma-secretase)-deficient cells and in normal cells treated with gamma-secretase inhibitors. Oxidative stress-induced beta-secretase activity and sAPPbeta levels were suppressed by gamma-secretase inhibitors. Levels of gamma- and beta-secretase activities were greater in brain tissue samples from AD patients compared to non-demented control subjects, and the elevated BACE1 level in the brains of 3xTgAD mice was reduced by treatment with a gamma-secretase inhibitor. Our findings suggest that gamma-secretase mediates oxidative stress-induced expression of BACE1 resulting in excessive Abeta production in AD. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687504      PMCID: PMC2858254          DOI: 10.1016/j.neurobiolaging.2008.07.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  31 in total

1.  Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

Authors:  Jie Zhao; Yifan Fu; Marina Yasvoina; Peizhen Shao; Brian Hitt; Tracy O'Connor; Sreemathi Logan; Erika Maus; Martin Citron; Robert Berry; Lester Binder; Robert Vassar
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

2.  Response to: Pardossi-Piquard et al., "Presenilin-Dependent Transcriptional Control of the Abeta-Degrading Enzyme Neprilysin by Intracellular Domains of betaAPP and APLP." Neuron 46, 541-554.

Authors:  Allen C Chen; Dennis J Selkoe
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

3.  Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes.

Authors:  Sébastien S Hébert; Lutgarde Serneels; Alexandra Tolia; Katleen Craessaerts; Carmen Derks; Mikhail A Filippov; Ulrike Müller; Bart De Strooper
Journal:  EMBO Rep       Date:  2006-05-19       Impact factor: 8.807

4.  Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke.

Authors:  Thiruma V Arumugam; Sic L Chan; Dong-Gyu Jo; Gokhan Yilmaz; Sung-Chun Tang; Aiwu Cheng; Marc Gleichmann; Eitan Okun; Vishwa D Dixit; Srinivasulu Chigurupati; Mohamed R Mughal; Xin Ouyang; Lucio Miele; Tim Magnus; Suresh Poosala; D Neil Granger; Mark P Mattson
Journal:  Nat Med       Date:  2006-05-07       Impact factor: 53.440

5.  Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Authors:  K S Montine; E Reich; M D Neely; K R Sidell; S J Olson; W R Markesbery; T J Montine
Journal:  J Neuropathol Exp Neurol       Date:  1998-05       Impact factor: 3.685

6.  Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP.

Authors:  Raphaëlle Pardossi-Piquard; Agnès Petit; Toshitaka Kawarai; Claire Sunyach; Cristine Alves da Costa; Bruno Vincent; Sabine Ring; Luciano D'Adamio; Jie Shen; Ulrike Müller; Peter St George Hyslop; Frédéric Checler
Journal:  Neuron       Date:  2005-05-19       Impact factor: 17.173

7.  Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.

Authors:  Xiulian Sun; Guiqiong He; Hong Qing; Weihui Zhou; Frederick Dobie; Fang Cai; Matthias Staufenbiel; L Eric Huang; Weihong Song
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

Review 8.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 9.  Presenilin diversifies its portfolio.

Authors:  Annette L Parks; Daniel Curtis
Journal:  Trends Genet       Date:  2007-02-05       Impact factor: 11.639

10.  Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice.

Authors:  Q Guo; W Fu; B L Sopher; M W Miller; C B Ware; G M Martin; M P Mattson
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

View more
  42 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

2.  Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease.

Authors:  A-Ryeong Gwon; Jong-Sung Park; Thiruma V Arumugam; Yong-Kook Kwon; Sic L Chan; Seol-Hee Kim; Sang-Ha Baik; Sunghee Yang; Young-Kwang Yun; Yuri Choi; Saerom Kim; Sung-Chun Tang; Dong-Hoon Hyun; Aiwu Cheng; Charles E Dann; Michel Bernier; Jaewon Lee; William R Markesbery; Mark P Mattson; Dong-Gyu Jo
Journal:  Aging Cell       Date:  2012-04-09       Impact factor: 9.304

Review 3.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

4.  A lifetime of dedication to the old in his Kentucky home.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2010-07-08       Impact factor: 3.843

5.  High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.

Authors:  Hisham Qosa; Loqman A Mohamed; Sweilem B Al Rihani; Yazan S Batarseh; Quoc-Viet Duong; Jeffrey N Keller; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

Review 6.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 7.  ER calcium and Alzheimer's disease: in a state of flux.

Authors:  Mark P Mattson
Journal:  Sci Signal       Date:  2010-03-23       Impact factor: 8.192

8.  Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.

Authors:  So Jung Park; Ji Hyun Shin; Jae In Jeong; Ji Hoon Song; Yoon Kyung Jo; Eun Sung Kim; Eunjoo H Lee; Jung Jin Hwang; Eun Kyung Lee; Sun Ju Chung; Jae-Young Koh; Dong-Gyu Jo; Dong-Hyung Cho
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1-42 on neural progenitor cell proliferation.

Authors:  Yan Hou; Paritosh Ghosh; Ruiqian Wan; Xin Ouyang; Heping Cheng; Mark P Mattson; Aiwu Cheng
Journal:  Neurobiol Aging       Date:  2013-11-13       Impact factor: 4.673

Review 10.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.